Dermatology — A Growth Opportunity For Those Willing To Risk Colossal Failure
Source: Life Science Leader
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Ever experience a Phase 3 failure?
How about one resulting in a stock price drop of 80 percent?
What about a Phase 3 failure where your company’s stock price plummets 85 percent and you agree to teach about the experience (for roughly 10 years) to a class of MBA students (while continuing to work full time in industry) at one of the most prestigious business schools in the country?
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more